February 12, 2018, USPSTF. We agree with the USPSTF that current evidence is insufficient to assess potential benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP), or coronary artery calcification (CAC) score to the traditional risk assessments for CVD.
Read More »How Adults Can Prevent Disease
NCHR Comments on USPSTF Draft Screening Recommendations for Peripheral Artery Disease (PAD)
USPSTF, February 12, 2018. In order to more widely recommend ABI, we need more studies directly evaluating both the efficacy and harms. Most importantly, we encourage the USPSTF to review studies that analyze the accuracy of ABI and its effect on improving health outcomes in asymptomatic PAD patients.
Read More »NCHR and WomenHeart Comments on USPSTF Draft Recommendation Statement Cardiovascular Disease Risk: Screening with Electrocardiography (ECG)
Jan 22, 2018, We commend the USPSTF for reviewing the evidence and developing evidence-based recommendations. There is substantial evidence to recommend against screening in low risk adults and is insufficient to support screening in higher risk adults.
Read More »Cancer of the Immune System (ALCL) and Breast Implants: Plastic Surgeons Study 173 Women
ALCL (Anaplastic Large Cell Lymphoma) develops near a breast implant but is not breast cancer – it is a cancer of the immune system. Physicians identified 173 women with ALCL to study this cancer caused by breast implants.
Read More »Breast Implants and Cancer of the Immune System (ALCL): A History of Who Knew What When
The FDA has reported growing evidence that breast implants are associated with anaplastic large cell lymphoma (ALCL), a rare cancer of the immune system.
Read More »